Advertisement

Cholesteryl Ester Transfer Protein, Coronary Calcium, and Intima-Media Thickness of the Carotid Artery in Middle-Age Japanese Men

      The relation between cholesteryl ester transfer protein (CETP) levels and atherosclerosis is controversial. We examined whether the serum CETP levels were associated with subclinical atherosclerosis, independent of its most common gene variant, in a sample of Japanese men. A population-based cross-sectional study of 250 Japanese men aged 40 to 49 years was conducted to assess the intima-media thickness of the carotid artery, coronary artery calcium, serum CETP levels, and the CETP D442G gene variant. Compared with the lowest CETP quartile, the multivariate adjusted odds ratio for coronary artery calcium was 0.77 (95% confidence interval 0.18 to 3.36), 0.96 (95% confidence interval 0.27 to 3.40), and 3.49 (95% confidence interval 1.05 to 11.6) with increasing CETP quartiles. The serum CETP quartiles were also positively associated with the intima-media thickness of the carotid artery (adjusted mean 602, 616, 615, and 646 μm for the lowest to top quartile, respectively). The findings remained unchanged after additional adjustment for the CETP D442G gene variant. No significant difference was found in the prevalence of coronary artery calcium or in the mean intima-media thickness of the carotid artery between participants with and without the CETP D442G gene variant.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tall A.R.
        Plasma cholesteryl ester transfer protein.
        J Lipid Res. 1993; 34: 1255-1274
        • Rumana N.
        • Kita Y.
        • Turin T.C.
        • Murakami Y.
        • Sugihara H.
        • Morita Y.
        • Tomioka N.
        • Okayama A.
        • Nakamura Y.
        • Ueshima H.
        Seasonal pattern of incidence and case fatality of acute myocardial infarction in a Japanese population (from the Takashima AMI Registry, 1988–2003).
        Am J Cardiol. 2008; 102: 1307-1311
        • Okamura T.
        • Kokubo Y.
        • Watanabe M.
        • Higashiyama A.
        • Miyamoto Y.
        • Yoshimasa Y.
        • Okayama A.
        Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study.
        Atherosclerosis. 2009; 203: 587-592
        • Inazu A.
        • Jiang X.C.
        • Haraki T.
        • Yagi K.
        • Kamon N.
        • Koizumi J.
        • Mabuchi H.
        • Takeda R.
        • Takata K.
        • Moriyama Y.
        • Doi M.
        Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.
        J Clin Invest. 1994; 94: 1872-1882
        • Sekikawa A.
        • Ueshima H.
        • Kadowaki T.
        • El-Saed A.
        • Okamura T.
        • Takamiya T.
        • Kashiwagi A.
        • Edmundowicz D.
        • Murata K.
        • Sutton-Tyrrell K.
        • Maegawa H.
        • Evans R.W.
        • Kita Y.
        • Kuller L.H.
        Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-World War II birth cohort.
        Am J Epidemiol. 2007; 165: 617-624
        • Okamura T.
        • Kadowaki T.
        • Sekikawa A.
        • Murata K.
        • Miyamatsu N.
        • Nakamura Y.
        • El-Saed A.
        • Kashiwagi A.
        • Maegawa H.
        • Nishio Y.
        • Takamiya T.
        • Kanda H.
        • Mitsunami K.
        • Kita Y.
        • Edmundowicz D.
        • Tamaki S.
        • Tsujita Y.
        • Kuller L.H.
        • Ueshima H.
        Alcohol consumption and coronary artery calcium in middle-aged Japanese men.
        Am J Cardiol. 2006; 98: 141-144
        • Nakamura Y.
        • Ueno Y.
        • Tamaki S.
        • Kadowaki T.
        • Okamura T.
        • Kita Y.
        • Miyamatsu N.
        • Sekikawa A.
        • Takamiya T.
        • El-Saed A.
        • Sutton-Tyrrell K.
        • Ueshima H.
        Fish consumption and early atherosclerosis in middle-aged men.
        Metabolism. 2007; 56: 1060-1064
        • Sekikawa A.
        • Curb J.D.
        • Ueshima H.
        • El-Saed A.
        • Kadowaki T.
        • Abbott R.D.
        • Evans R.W.
        • Rodriguez B.L.
        • Okamura T.
        • Sutton-Tyrrell K.
        • Nakamura Y.
        • Masaki K.
        • Edmundowicz D.
        • Kashiwagi A.
        • Willcox B.J.
        • Takamiya T.
        • Mitsunami K.
        • Seto T.B.
        • Murata K.
        • White R.L.
        • Kuller L.H.
        • ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group
        Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese Americans, and whites: a cross-sectional study.
        J Am Coll Cardiol. 2008; 52: 417-424
        • Sasai K.
        • Okumura-Noji K.
        • Hibino T.
        • Ikeuchi R.
        • Sakuma N.
        • Fujinami T.
        • Yokoyama S.
        Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients.
        Clin Chem. 1998; 44: 1466-1473
        • Kokubo Y.
        • Okamura T.
        • Yoshimasa Y.
        • Miyamoto Y.
        • Kawanishi K.
        • Kotani Y.
        • Okayama A.
        • Tomoike H.
        Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study.
        Hypertens Res. 2008; 31: 2027-2035
        • Agatston A.S.
        • Janowitz W.R.
        • Hildner F.J.
        • Zusmer N.R.
        • Viamonte Jr, M.
        • Detrano R.
        Quantification of coronary artery calcium using ultrafast computed tomography.
        J Am Coll Cardiol. 1990; 15: 827-832
        • Thompson T.
        • Sutton-Tyrrell K.
        • Wildman R.
        Continuous quality assessment programs can improve carotid duplex scan quality.
        J vasc Technol. 2001; 25: 33-39
        • Barter P.J.
        • Brewer Jr, H.B.
        • Chapman M.J.
        • Hennekens C.H.
        • Rader D.J.
        • Tall A.R.
        Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
        Arterioscler Thromb Vasc Biol. 2003; 23: 160-167
        • Hirano K.
        • Yamashita S.
        • Nakajima N.
        • Arai T.
        • Maruyama T.
        • Yoshida Y.
        • Ishigami M.
        • Sakai N.
        • Kameda-Takemura K.
        • Matsuzawa Y.
        Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
        Arterioscler Thromb Vasc Biol. 1997; 17: 1053-1059
        • Boekholdt S.M.
        • Kuivenhoven J.A.
        • Wareham N.J.
        • Peters R.J.
        • Jukema J.W.
        • Luben R.
        • Bingham S.A.
        • Day N.E.
        • Kastelein J.J.
        • Khaw K.T.
        Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
        Circulation. 2004; 110: 1418-1423
        • Föger B.
        • Luef G.
        • Ritsch A.
        • Schmidauer C.
        • Doblinger A.
        • Lechleitner M.
        • Aichner F.
        • Patsch J.R.
        Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness.
        J Mol Med. 1995; 73: 369-372
        • Zhuang Y.
        • Wang J.
        • Qiang H.
        • Li Y.
        • Lui X.
        • Li L.
        • Chen G.
        Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients.
        Clinica Chim Acta. 2001; 305: 19-25
        • Klerkx A.H.
        • de Grooth G.J.
        • Zwinderman A.H.
        • Jukema J.W.
        • Kuivenhoven J.A.
        • Kastelein J.J.
        Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
        Eur J Clin Invest. 2004; 34: 21-28
        • Colhoun H.M.
        • Scheek L.M.
        • Rubens M.B.
        • Van Gent T.
        • Underwood S.R.
        • Fuller J.H.
        • Van Tol A.
        Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.
        Diabetes. 2001; 50: 652-659
        • de Vries R.
        • Perton F.G.
        • Dallinga-Thie G.M.
        • van Roon A.M.
        • Wolffenbuttel B.H.
        • van Tol A.
        • Dullaart R.P.
        Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.
        Diabetes. 2005; 54 (3554–2559)
        • Barter P.J.
        • Caulfield M.
        • Eriksson M.
        • Grundy S.M.
        • Kastelein J.J.
        • Komajda M.
        • Lopez-Sendon J.
        • Mosca L.
        • Tardif J.C.
        • Waters D.D.
        • Shear C.L.
        • Revkin J.H.
        • Buhr K.A.
        • Fisher M.R.
        • Tall A.R.Brewer B.
        • ILLUMINATE Investigators
        Effects of torcetrapib in patients at high risk for coronary events.
        N Engl J Med. 2007; 357: 2109-2122
        • Nissen S.E.
        • Tardif J.C.
        • Nicholls S.J.
        • Revkin J.H.
        • Shear C.L.
        • Duggan W.T.
        • Ruzyllo W.
        • Bachinsky W.B.
        • Lasala G.P.Tuzcu E.M.
        • ILLUSTRATE Investigators
        Effect of torcetrapib on the progression of coronary atherosclerosis.
        N Engl J Med. 2007; 356: 1304-1316
        • Bots M.L.
        • Visseren F.L.
        • Evans G.W.
        • Riley W.A.
        • Revkin J.H.
        • Tegeler C.H.
        • Shear C.L.
        • Duggan W.T.
        • Vicari R.M.
        • Grobbee D.E.Kastelein J.J.
        • RADIANCE 2 Investigators
        Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.
        Lancet. 2007; 370: 153-160
        • Vergeer M.
        • Bots M.L.
        • van Leuven S.I.
        • Basart D.C.
        • Sijbrands E.J.
        • Evans G.W.
        • Grobbee D.E.
        • Visseren F.L.
        • Stalenhoef A.F.
        • Stroes E.S.
        • Kastelein J.J.
        Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.
        Circulation. 2008; 118: 2515-2522
        • Curb J.D.
        • Abbott R.D.
        • Rodriguez B.L.
        • Masaki K.
        • Chen R.
        • Sharp D.S.
        • Tall A.R.
        A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly.
        J Lipid Res. 2004; 45: 948-953
        • Hirano K.
        • Yamashita S.
        • Nakajima N.
        • Arai T.
        • Maruyama T.
        • Yoshida Y.
        • Ishigami M.
        • Sakai N.
        • Kameda-Takemura K.
        • Matsuzawa Y.
        Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
        Arterioscler Thromb Vasc Biol. 1997; 17: 1053-1059
        • Moriyama Y.
        • Okamura T.
        • Inazu A.
        • Doi M.
        • Iso H.
        • Mouri Y.
        • Ishikawa Y.
        • Suzuki H.
        • Iida M.
        • Koizumi J.
        • Mabuchi H.
        • Komachi Y.
        A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
        Prev Med. 1998; 27: 659-667
        • Nicholls S.J.
        • Tuzcu E.M.
        • Brennan D.M.
        • Tardif J.C.
        • Nissen S.E.
        Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).
        Circulation. 2008; 118: 2506-2514
        • van Venrooij F.V.
        • Stolk R.P.
        • Banga J.D.
        • Sijmonsma T.P.
        • van Tol A.
        • Erkelens D.W.
        • Dallinga-Thie G.M.
        • DALI Study Group
        Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
        Diabetes Care. 2003; 26: 1216-1223